Clinical trial Recruiting at 1 site Interventional Ages 18 to 40 Women only

PPOS versus GnRH antagonist IVF protocols for women with PCOS

Official title: A Comparative Study of In Vitro Fertilization Outcomes Between PPOS and Antagonist Protocols in Women With Polycystic Ovary Syndrome

Run by Hanoi General Hospital (Vietnam) · NCT07394530 · Data updated 2026-11-12

This trial will test whether a progestin-primed ovarian stimulation (PPOS) protocol or a GnRH antagonist protocol gives better IVF outcomes for women aged 18–40 with PCOS.

Quick facts

Study typeInterventional
Ages18 Years to 40 Years
SexWomen only
Enrollment400 (estimated)
SponsorHanoi General Hospital (Vietnam)
Academic / other
Locations1 site (Hanoi, Hanoi)
StatusRecruiting
StartedJanuary 20, 2026
Main results expectedJune 30, 2027
Study endsJune 30, 2028
Registry record updatedAugust 5, 2026
Trial IDNCT07394530 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Women aged 18–40 diagnosed with PCOS by the modified Rotterdam criteria who are planning IVF and whose partners have normal or only mildly to moderately abnormal sperm are the intended participants.

Probably not a fit

Women with significant uterine abnormalities, major prior ovarian or uterine surgery affecting reserve or structure, or other exclusionary conditions are unlikely to benefit from participating.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Women meeting modified Rotterdam criteria for PCOS who are indicated for IVF will receive one of two controlled ovarian stimulation approaches: a progestin-primed ovarian stimulation (PPOS) protocol or a GnRH antagonist protocol. Key IVF outcomes such as number of oocytes retrieved, fertilization and embryo quality, pregnancy rates, and rates of complications (including ovarian hyperstimulation) will be recorded and compared between groups. Eligible participants are 18–40 years old, have PCOS, and a partner with normal or mildly-to-moderately abnormal sperm parameters; major uterine or prior ovarian surgery that impairs outcomes are exclusionary. The protocol is conducted at Hanoi General Hospital with standard IVF monitoring and follow-up visits.

Why it matters

Potential benefit: If successful, the results could help clinicians choose the stimulation method that yields more eggs or higher pregnancy rates while reducing complications for women with PCOS.

How similar studies have gone: Previous studies comparing PPOS and antagonist protocols have generally reported similar embryo yield and pregnancy rates, with some evidence that PPOS can reduce ovarian hyperstimulation risk, though results are mixed.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Women aged 18-40 years
* Diagnosed with polycystic ovary syndrome (PCOS) according to the modified Rotterdam criteria (2004) (≥2 of 3: oligo/anovulation, hyperandrogenism, or polycystic ovarian morphology on ultrasound)
* Indicated for in vitro fertilization (IVF) due to PCOS alone or PCOS with other infertility factors (e.g., tubal factor, previous failed IUI)
* Eligible for controlled ovarian stimulation for IVF
* Husband/partner with normal sperm parameters or mild to moderate oligoasthenoteratozoospermia (OAT)
* Willing and able to provide written informed consent and comply with study procedures.

Exclusion Criteria:

* Uterine abnormalities that may impair implantation or pregnancy outcomes, including congenital uterine malformations, large fibroids distorting the uterine cavity, adenomyosis, or severe intrauterine pathology.
* History of major ovarian or uterine surgery affecting ovarian reserve or uterine structure (e.g., ovarian cystectomy, endometriosis surgery, myomectomy, unilateral oophorectomy)
* History of recurrent pregnancy loss (≥3 spontaneous miscarriages)
* Known chromosomal abnormalities in either partner
* Inability to adhere to study protocol or follow-up procedures

Where it's running

  • Hanoi General Hospital
    Hanoi, Hanoi, Vietnam
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Using LC-MS/MS to profile androgens for PCOS diagnosis

    This study tests whether LC-MS/MS measurement of androgen profiles can help diagnose PCOS in women compared with healthy controls.

    Recruiting Women's Hospital School Of Medicine Zhejiang University · Hangzhou, Zhejiang · NCT07916909

  • Brown adipose tissue responses in PCOS with infrared thermography and inositol

    This study tests whether brown fat activity, measured by infrared skin temperature and UCP-1 levels, differs among women with PCOS (normal weight or overweight/obese) and healthy controls, and whether 12 weeks of inositol changes those responses in overweight/obese PCOS participants.

    Recruiting at 2 sites Istanbul Health and Technology University · Istanbul and 1 other locations · NCT07896642

  • Risk tool for blood-clotting problems in adolescents and women with PCOS

    This project will try to build a risk model to spot decreased protein C or S and other clotting abnormalities in females aged 14–45 who have PCOS.

    Recruiting Guangdong Women and Children Hospital · Guangzhou, Guangdong · NCT07571096

  • Blocking RANKL with denosumab to protect ovarian follicles

    This trial will test whether giving denosumab, a drug that blocks RANKL, can help protect follicle development in women with infertility who are undergoing assisted reproduction.

    Recruiting Regionshospitalet Viborg, Skive · Skive, Midt Jylland · NCT07546552

  • Effect of a 21-day comprehensive spa program on female infertility

    This study tests whether a 21-day spa treatment can impact hormonal profiles and reproductive outcomes in women ages 20-40 with infertility.

    Recruiting Institute of Spa and Balneology, public research institution · Františkovy Lázně, Carlsbad Region · NCT07542600

  • Endometrial immune profile changes after putting your own PRP into the uterus

    This test will try whether putting a person's own platelet-rich plasma (PRP) into the uterus improves the uterine immune profile, thickness, hormone levels, and pregnancy rates for people undergoing IVF with euploid embryo transfer.

    Recruiting Nadezhda Women's Health Hospital · Sofia, Sofia · NCT07535190

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.